Bi-weekly Member Newsletter                                             July 21, 2017
Keep up-to-date with the latest legislative and regulatory news. Visit IACP's websiteArchived  Capitol Connections  newsletters here. Send your suggestions and questions to  iacpinfo@iacprx.org .
IACP/About                                                               

IACP EVP Cynthia Blankenship, ESQ.

Exciting News! IACP Announces its New Executive Vice President Cynthia Blankenship, ESQ. IACP is in the midst of reviewing & revitalizing ALL of our current programs. We want to ensure we're completely in tune with our membership, providing you with what you need!  More details   including recent Town Hall recording.

Keep the Momentum Going - please Contribute to IACP's One Fund. Make the donation that will help preserve patient access to compounded medications and help support IACP's HR 2871 efforts. IACP is working to Protect, Promote & Advance Pharmacy Compounding.

Now thru August - Sign Up your Staff for 25% off NEW IACP Memberships. New Staff Compounding Pharmacist, Non-Compounding Pharmacist/Retired/Full-Time Faculty, Technician and Friends of Compounding memberships. Use code CCH25, click here to save!

IACP's Prescription Billing Accountability Position Statement states, "IACP believes public and private health care payers should aggressively address health care fraud, including taking action against any health care provider that has allegedly broken the law. If a provider has misrepresented what they have dispensed or has not followed law or regulation, they should be held fully accountable." More here. Please email iacpinfo@iacprx.org  with questions.
Federal Advocacy

HR 2871 has 15 Cosponsors! Has Your Representative Signed On?  Sending a direct communication to your Representative will only take a few minutes with IACP's easy-to-use Voter Voice action alert platform. HR 2871 will help protect access to compounded medications on which your patients rely. It will help clarify the Drug Quality & Security Act (DQSA) in a way that will better align the statute with congressional intent and better balance public safety and patient access.  Act, Today !

IACP's Congressional Recess Packet Now Available! IACP is providing the tools you need to host a successful congressional district visit as the 115th U.S. Congress goes on summer recess, July 31 - September 4, 2017. This Congressional Recess, it's crucial to ask your Member of Congress for their support of HR 2871 - The Preserving Patient Access to Compounded Medications Act of 2017 introduced by Congressman Morgan Griffith (VA) and Congressman Henry Cuellar (TX) . Check out IACP's Congressional Packet!

IACP Applauds the Leadership of the  U.S. House of Representatives Committee on Appropriations as it released its Full Committee Report on the FY 2018 Agriculture Appropriations Bill on Wednesday, July 12, 2017. We are so grateful to all the champions of Compounding that rose during the Full Committee Markup, and expressed support for preserving patient access for compounded medications. Read more details.
Click here to send a direct message to your Representatives:
Support HR 2871 !
State Advocacy

Compounders Stateside is IACP's members-only one-stop resource for state legislative and regulatory updates! Be sure to visit weekly for the latest activity in your state. 

Compounders Stateside is an exclusive IACP benefit - you will need to log in to access this week's report .

State Alerts
IACP Submits Comments to California State Board of Pharmacy

IACP Submits Comments to the California Board of Pharmacy  for its upcoming July 25, 2017 meeting. From the letter - "Specifically, within Part 2 of Agenda Item VI, the California Board of Pharmacy, Enforcement & Compounding Committee will be providing the Board with proposed recommendations to CCR Sections 1735 - 1735.8 as a result of the Committee's June 2, 2017 and July 12, 2017 meetings. While IACP commends the Committee for collaborating with the compounding community in developing these proposed amendments, an area of major concerns that remains open is the Committee's perspective on the type of information a compounding pharmacist is permitted to use when assigning a Beyond-Use Date (BUD) to a sterile compound."
Grassroots


Spread the word. Become a Partnership for Personalized Prescriptions (P3) advocate! 
Urge your patients and physicians to join the effort to protect patient access to compounded medications! Let's Educate, Advocate, Protect & Advance Patients' Access to 
Customized Medications. 

Stay tuned for a P3 Advocacy Packet!

IACP MEMBERS: We NEED your patient stories - how have compounded medications helped your community? Please email Dagmar Anderson, IACP VP Communications, at dagmar@iacprx.org.

Keep the Momentum Going!  Please  Contribute to IACP's One Fund!

News:  IACP in the News

Inside Health Policy House Appropriators Send FDA Funding Bill to Floor By Voice Vote July 12, 2017 (requires subscription - article synopsis below.)

* The House Appropriations Committee advanced a fiscal 2018 FDA funding bill to the floor Wednesday (July 12) by voice vote, maintaining $2.8 billion in discretionary funding for the agency and adding $60 million to implement the 21st Century Cures Act. Debate sparked over an amendment which would have allowed office-use compounding where authorized by state law, but it was withdrawn after Rep. Robert Aderholt (R-GA) promised to work on the issue in the future with Rep. Chris Stewart (R-UT).

* The committee adopted the manager's amendment by unanimous voice vote. One provision added in the manager's amendment urges FDA to issue guidance on the use of colorants in feminine hygiene cosmetic products, and issue a prompt final response to the associated citizen petition by Women's Voices for the Earth filed August 18, 2015. Another addition directs FDA to hold a public meeting on the regulation of medical gases and provide Congress a written report by Dec. 31 on planned regulatory actions.


Jennifer Burch, PharmD - Evelyn 
Timmons Award
Members in the News
  • IACP Board Member Jennifer Burch, PharmD, Central Compounding Center, Durham N.C., has been named IACP Corporate Partner PCCA's Evelyn Timmons Advocacy Award winner. Congratulations, Jennifer! More here.

  • Becca Mitchell, PharmD, FIACP, US Compounding Pharmacy in Conway, Ark., has been appointed to the Arkansas State Board of PharmacyCongratulations, Becca! Arkansas Board members here.

IACP President Baylor Rice, RPh, FIACP
International News

IACP President Baylor Rice, RPh, FIACP, suggests some summer reading for you! He highly recommends an article appearing in our Corporate Partner International Journal of Pharmaceutical Compounding (IJPC's) July 3rd CompoundingToday.com newsletter. 

Check out Dr. Maria Carvalho's PhD dissertation (free download) "Extemporaneously Compounded Oral Medicines in European Hospital Pharmacies." It's an excellent read and provides a current resource on compounding in European hospitals. It can be downloaded here. Thank you Dr. Carvalho and IJPC for bringing us this excellent information. For a free trial and more information on IJPC's CompoundingToday.Com, please visit.
Events & Education Update


Public Affairs Industry Partner Update in St. Louis, Missouri on August 10, 2017. Meet IACP's New EVP Cynthia Blankenship! IACP, National Community Pharmacists Association and PCCA will present the latest compounding industry legislative and regulatory information as you earn CE, enjoy appetizers, and the company of your colleagues. Register and more information.  



Attendee Advanced Registration Discount Ends Wednesday, August 2, 2017 at MIDNIGHT!

Save the Date: IACP's Educational Conference
Sonesta Fort Lauderdale Beach 
January 24-27, 2018!  #EduCon2018

Attendee Registration Opens End of July! Exhibitor Prospectus Release in August! 

IACP's Educational Conference, January 24-27, 2018, Sonesta Fort Lauderdale Beach in Florida! Obtain CE by the SEA, and network with your colleagues as IACP brings you unique programming no one else can provide!
Corporate Partner Spotlight: Hardy Diagnostics

Your USP <797> Compliance Specialists in Microbiology

Hardy Diagnostics has been a trusted manufacturer of microbiological culture media for 35 years and offers many quality products to help with your compliance program and in-house testing. 

Our HardyVal™ Aseptic Media Fill Challenge Test Kits and a-la-carte components make compliance easy! Choose from our pre-assembled Media Fill Test Kits or design your own challenge to simulate your compounding processes. 
More information here!

Corporate Partner News

  • SP Scientific announces ControLyo® Central, a new suite of online resources detailing how ControLyo® Technology works and its benefits, as well as research publications and brochures.
IACP Foundation Update

IACP Foundation's 13th Annual Rx Mixer - Rx Around the Clock benefiting the IACP Foundation was held Sunday, June 11, 2017 from 7:00 pm - Midnight at the Washington Marriott Wardman Park.

Event Co-Chairs, Erin Michael, MBA, CPhT and Jennifer Petska, BS, CPhT, with their Rx Mixer Committee, raised money through sponsorships and the auction. More details here!
IACP| 281.933.8400 | iacpinfo@iacprx.org | iacprx.org
STAY CONNECTED:

(C) IACP 2017